Navigation Links
Life Technologies Signs Exclusive License Agreement for TAL Effector Technology That Enables Synthetic Biologists to Precisely Control Gene Expression in Engineered Organisms
Date:6/10/2011

broad areas of research and development.

"A key factor in the successful design and functionality of synthetically-based organisms is the ability to precisely regulate their metabolic pathways," said Nathan Wood, Vice President of Synthetic Biology for Life Technologies.  "TAL Effector Technology can fulfill that need by offering the first molecular tool to reliably design control mechanisms in cells."

By unveiling the fundamental code that details how TAL Effectors target specific genomic regions, the technology's inventors have provided scientists with a powerful tool to specifically target and engineer precise genetic control and to predictably affect other cellular functions.

The ability to control expression in target areas within a genome is pivotal for synthetic biologists working to develop a variety of chemical-producing organisms for purposes that could help solve some of the world's preeminent challenges. Such applications may include the development of biofuels to decrease society's dependence on fossil fuels, new vaccines to improve human health, or higher-yielding food crops that are more resistant to changing weather patterns.

TAL Effector Technology, broadly licensed by Life Technologies, was developed in Germany and licensed originally by 2Blades for all applications in plants, and augments Life Technologies' growing portfolio of tools and capabilities it offers to the synthetic biology community. Life Technologies initially plans to make TAL Effector Technology available via its GeneArt gene synthesis portfolio. However, this enabling technology has far broader applications than synthetic biology and will be developed for use in many other fields such as bioproduction, stem cell research and drug discovery.

About Life Technologies (www.lifetec
'/>"/>

SOURCE Life Technologies Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
2. RainDance Technologies Appoints Olex Vice President, System Development
3. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
4. Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing
5. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration
8. Anthill Technologies Announces Agreement With Zafgen
9. Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results
10. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
11. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Calif. , May 23, 2013 ... a strategic alliance with DAK Renewable Research to ... corn oil yield. VG Energy is a majority ... Pink: VGLS). VG Energy,s exclusively licensed ... increase the oil yield in plants, possessing a ...
(Date:5/23/2013)... Ill. , May 23, 2013 Z ... providing value-added ingredients to a variety of industries, announced ... in a panel discussion at this year,s National Restaurant ... 20-21, 2013, on behalf of the Research Chefs Association.  ... for Restaurants: The Good, the Bad and the Ugly," ...
(Date:5/23/2013)... Canada (PRWEB) May 23, 2013 ... it is critical to adhere to principles of ... (HSP). , Esteemed speaker Dr. Jeremy Lim, Fellow, ... audience: , ,     Understand the International ... Practice (GCP) and additional regulations for the conduction ...
(Date:5/23/2013)... 2013 Bed bugs compromised Penn ... already confirmed it. Meanwhile, My Cleaning Products offered complimentary samples ... fight the pests without using harmful chemical elements. , ... 2013, the affected building was actually a dormitory , ... said made on May 13 and bed bug presence was ...
Breaking Biology Technology:VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims 2
... Institute/L&P Food Ingredient Co. Ltd. (GDFII/L&P) today announced that the U.S. ... date of its final decision in the sucralose case, from March ... 337-TA-604) was filed against the company by its main competitor, Tate ... ...
... Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) today announced that ... for the planned Phase II dose escalation study of ... company,s perfluorocarbon (PFC) therapeutic oxygen carrier. The Israeli sites ... physicians are excited to be able to participate in ...
... CRTX ), a specialty pharmaceutical company focused on acquiring, developing and commercializing ... the year ended December 31, 2008. Highlights: , ... Revenues more than doubled to $64.9 Million, an increase of 131% , ... Income from Operations increased to $10.6 ...
Cached Biology Technology:GDFII/L&P Confirms Target Date Extension Of U.S. ITC Sucralose Ruling 2Oxygen Biotherapeutics, Inc. Adds Oxycyte TBI Clinical Trial Sites in Israel 2Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 2Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 3Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 4Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 5Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 6Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 7Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 8Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 9Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 10Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 11Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 12
(Date:5/22/2013)... pneumophila bacteria is responsible for legionellosis, an infectious ... infect us, this pathogen has developed a complex method ... our cells, thus avoiding these acting against the infectious ... centre, CIC bioGUNE, in which teams from the National ... National Supercomputation Centre in Barcelona (BSC) have also participated, ...
(Date:5/22/2013)... Early screening for prostate cancer could become as ... women, thanks to UC Irvine research published today in ... , After more than a decade of work, UC ... clinically usable markers for prostate cancer in urine, meaning ... greater accuracy and at dramatically lower cost. The same ...
(Date:5/22/2013)... known as phthalates (pronounced THAL-ates) are odorless, colorless ... flooring, plastic cups, beach balls, plastic wrap, intravenous ... and Preventionthe bodies of most Americans. Once perceived ... A growing collection of evidence suggests dietary exposure ... mix with food) may cause significant metabolic and ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2
... highly active antiretroviral therapy (HAART) for HIV infection remain ... for HIV-infected patients not on HAART, according to an ... Diseases, now available online. , Opportunistic infections such ... HAART not only reduces the viral load of HIV, ...
... and brain sciences Peter Tse has published new results ... it transforms visual stimuli into conscious experience. , His ... unattended targets are confined to areas in the occipital ... 8 issue of the weekly journal, The Proceedings of ...
... gene into neurons of the tiny, transparent nematode ... specific behavioral responses by simply illuminating animals with ... better understanding of how neurons communicate with each ... intact, living organisms. Generally speaking, detailed information about ...
Cached Biology News:Tuberculosis still a risk for patients receiving HIV drugs 2Finding the mind's eye 2Algal protein in worm neurons allows remote control of behavior by light 2
Peptide Sequence: ovine COX-1 amino acids 272-282 (LMHYPRGIPPQ) To be used in conjunction with Cayman's COX-1 (ovine) polyclonal antiserum (Catalog No. 160108) to block protein-antibody complex f...
Laminin beta-1/gamma-1 (612C10)...
... choice of Printing Surface (3 glass slides coated with ... 1 silicon wafer coated with 1000 Angstroms of Gold ... PDMS Stamps (3 PDMS micropatterned stamps with series of ... 10 mm or 200 um x 10 mm lines, ...
X box-binding protein 1...
Biology Products: